N-Methyl-d-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization

  • K. Fink
  • M. Göthert
  • G. Molderings
  • E. Schlicker


Rat brain cortex slices and synaptosomes (in a few experiments also hippocampal synaptosomes) preincubated with 3H-noradrenaline, 3H-5-hydroxytryptamine, 3H-choline, 3H-glutamate or 3H-γ-aminobutyric acid were used to investigate the 3H-transmitter release in response to exposure to N-methyl-d-aspartate (NMDA) and other excitatory amino acids. The slices and synaptosomes were superfused with Mg2+-free, otherwise physiologically composed salt solution.

In cortical slices preincubated with 3H-noradrenaline, NMDA concentration-dependently stimulated 3H overflow, whereas no such effect occurred in slices preincubated with 3H-5-hydroxytryptamine, 3H-choline, 3H-λutamate or 3H-γ-aminobutyric acid. In cortical slices preincubated with 3H-noradrenaline, the NMDA-evoked 3H overflow was abolished by tetrodotoxin, presence of Mg2+ 1.2 mmol/l or absence of Ca2+. 2-Amino-5-phosphonovaleric acid produced a parallel shift to the right of the NMDA concentration-response curve, whereas (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohept-5,10-imine hydrogen maleate (MK-801) not only shifted the concentration-response curve to the right but also reduced the maximum effect of NMDA. Other excitatory amino acid receptor agonists also stimulated 3H overflow, yielding the following rank order of potency: NMDA > l-glutamate > l-aspartate. Kainate and, in particular, quisqualate exhibited only low potencies and/or intrinsic activities. Prolonged (25 min) exposure of 3HNA-preincubated cortical slices to a high NMDA concentration produced a short-lasting peak of 3H overflow, followed by a second phase lasting as long as the compound was present; in this phase, 3H overflow was clearly less pronounced and gradually decreased with time. The stimulatory effect of a high NMDA concentration was concentration-dependently reduced by 20 min of pre-superfusion with NMDA or l-glutamate at concentrations which by themselves produced either no or, at the most, moderate increase in 3H efflux in the two 5-min periods before application of the NMDA stimulus; in contrast, the veratridine-evoked 3H overflow was increased by pre-exposure to these NMDA concentrations. Neither in 3H-noradrenaline-preincubated synaptosomes prepared from the cortex or hippocampus nor in cortical synaptosomes preincubated with 3H-5-hy-droxytryptamine did NMDA evoke 3H overflow. The veratridine-evoked 3H overflow from 3H-noradrenaline-preincubated cortical synaptosomes was not affected by simultaneous administration of NMDA.

It is concluded that NMDA selectively stimulates noradrenaline release in the rat brain cortex via NMDA receptors which appear not to be located on the noradrenergic nerve terminals. The NMDA receptor is rapidly desensitized in response to continuous application of NMDA (“tachyphylaxis”) or l-glutamate (“cross-tachyphylaxis”).

Key words

NMDA receptor Noradrenaline release Rat brain cortex l-Glutamate Excitatory amino acids Receptor desensitization 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Collingridge GL, Bliss TV (1987) NMDA receptors — their role in long-term potentiation. Trends Neurosci 10:288–293Google Scholar
  2. Cotman CW, Monaghan DT (1988) Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Ann Rev Neurosci 11:61–80Google Scholar
  3. Farnebo LO, Hamberger B (1971) Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl 371:35–44Google Scholar
  4. Fink K, Schlicker E, Molderings G, Göthert M (1988) N-Methyl-d-aspartate (NMDA) stimulates noradrenaline (NA) but not serotonin (5-HT) release in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 338 (Suppl): R 69Google Scholar
  5. Foster AC Fagg GE (1984) Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res Rev 7:103–164Google Scholar
  6. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental phamacology. Catecholamines, vol XXXIII. Springer, Berlin Heidelberg New York, pp 283–335Google Scholar
  7. Harrison NL, Simmonds MA (1985) Quantitative studies on some antagonists of N-methyl-d-aspartate in slices of rat cerebral cortex. Br J Pharmacol 84: 381–391Google Scholar
  8. Jones SM, Snell LD, Johnson KM (1987a) Phencyclidine selectively inhibits N-methyl-d-aspartate-induced hippocampal (3H)norepinephrine release. J Pharmacol Exp Ther 240:492–497Google Scholar
  9. Jones SM, Snell LD, Johnson KM (1987b) Inhibition by phencyclidine of excitatory amino acid-stimulated neurotransmitter release in the nucleus accumbens. Neuropharmacology 26:173 -179Google Scholar
  10. Lalies M, Middlemiss DN, Ransom R (1988) Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801. Neurosci Lett 91:339–342Google Scholar
  11. Lehmann J, Scatton B (1982) Characterization of the excitatory amino acid receptor mediated release of (3H)acetylcholine from rat striatal slices. Brain Res 252:77–89Google Scholar
  12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  13. Mayer ML, Westbrook GL, Guthrie PB (1984) Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 309:261–263Google Scholar
  14. Mulder AH, Van den Berg WB, Stoof JC (19785) Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system. Brain Res 99:419–425Google Scholar
  15. Nowak K, Bregestowski P, Ascher P, Herbet A, Prochiantz A (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462–465Google Scholar
  16. Ransom RW, Deschenes NL (1988) NMDA-induced hippocampal 3H norepinephrine release is modulated by glycine. Eur J Pharmacol 156:149–155Google Scholar
  17. Schmidt CJ, Taylor VL (1988) Release of 3H norepinephrine from rat hippocampal slices by N-methyl-d-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801. Eur J Pharmacol 156:111–120Google Scholar
  18. Shinozaki H (1988) Pharmacology of the glutamate receptor. Progr Neurobiol 30: 399–435Google Scholar
  19. Snell LD, Johnson KM (1985) Antagonism of N-methyl-d-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J Pharmacol Exp Ther 235:50–57Google Scholar
  20. Snell LD, Johnson KM (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J Pharmacol Exp Ther 238:938–946Google Scholar
  21. Snell LD, Jones SM, Johnson KM (1987) Inhibition of N-methyl-d-aspartate-induced hippocampal 3H norepinephrine release by phencyclidine is dependent on potassium concentration. Neurosci Lett 78:333–337Google Scholar
  22. Snell LD, Yi SJ, Johnson KM (1988) Comparison of the effects of MK 801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 145:223–226Google Scholar
  23. Stone TW, Burton NR (1988) NMDA receptors and ligands in the vertebrate CNS. Progr Neurobiol 10:333–368Google Scholar
  24. Wallenstein S, Zucker LL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9Google Scholar
  25. Watkins JC, Olverman HJ (1987) Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci 10:265–272Google Scholar
  26. Wilkins CJ, Godfrey PP, Watson SP (1988) MK 801 blocks NMDA but not kainate-mediated inhibition of stimulated inositide turnover in rat cerebral cortex. Br J Pharmacol 93:135PGoogle Scholar
  27. Wong EHF, Kemp JA, Priestly T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc Natl Acad Sci USA 83:7104–7108Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • K. Fink
    • 1
  • M. Göthert
    • 1
  • G. Molderings
    • 1
  • E. Schlicker
    • 1
  1. 1.Institut für Pharmakologie und Toxikologie der Rheinischen Friedrich-Wilhelms-Universität BonnBonn 1Federal Republic of Germany

Personalised recommendations